Summary
EnteroMedics Inc (Enteromedics) is a medical equipment provider that offers therapeutic and neuroregulator systems. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops VBLOC therapy used in the treatment of gastrointestinal and metabolic diseases. EnteroMedics offers maestro system, components, and other therapy products. The company’s VBLOC therapy is a pacemaker device, which is designed to control hunger. Its products are used in treatment of obesity, co-morbidities, hypertension and digestive disorders. Enteromedics is headquartered in St. Paul, Minnesota, the US.
EnteroMedics Inc (ETRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
EnteroMedics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
EnteroMedics Inc, Medical Devices Deals, 2011 to YTD 2017 10
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Equity Offering 12
EnteroMedics Prices Public Offering of Units for USD20 Million 12
Debt Offering 14
EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 14
EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 15
EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 16
Acquisition 17
EnteroMedics Acquires BarioSurg 17
EnteroMedics Inc - Key Competitors 18
EnteroMedics Inc - Key Employees 19
EnteroMedics Inc - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2017: EnteroMedics Announces Second Quarter 2017 Financial Results 21
May 16, 2017: EnteroMedics Announces First Quarter 2017 Financial Results 22
Mar 07, 2017: EnteroMedics Reports Fourth Quarter 2016 Financial Results 23
Nov 10, 2016: EnteroMedics Reports Third Quarter 2016 Financial Results 25
Aug 04, 2016: EnteroMedics Reports Second Quarter 2016 Financial Results 26
May 05, 2016: EnteroMedics Reports First Quarter 2016 Financial Results 27
Feb 17, 2016: EnteroMedics Reports Fourth Quarter 2015 Financial Results 28
Corporate Communications 29
Sep 27, 2016: EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors 29
Sep 07, 2016: EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer 30
Aug 17, 2016: EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors 31
Jan 22, 2016: EnteroMedics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 32
Product News 33
Dec 15, 2016: Commercial Patient Data Confirms Success of EnteroMedics' vBloc Therapy in Combination with vBloc Achieve Program in Patients Struggling to Lose Weight 33
Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity 34
Jan 05, 2017: EnteroMedics Announces vBloc Neurometabolic Therapy Now Available at MedStar Health and Roper St. Francis 35
Other Significant Developments 36
Nov 22, 2016: EnteroMedics Provides Commercialization and Corporate Update 36
Feb 02, 2016: Winthrop-University Hospital Becomes First Employer in the U.S. to Cover Innovative Obesity Treatment vBloc Therapy 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
EnteroMedics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
EnteroMedics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
EnteroMedics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
EnteroMedics Inc, Medical Devices Deals, 2011 to YTD 2017 10
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
EnteroMedics Prices Public Offering of Units for USD20 Million 12
EnteroMedics Raises USD6.2 Million in Third Tranche of Private Placement of 7% Notes Due 2017 14
EnteroMedics Raises USD11 Million in Second Tranche of Private Placement of 7% Notes Due 2017 15
EnteroMedics Raises USD1.5 Million in First Tranche of Private Placement of 7% Notes Due 2017 16
EnteroMedics Acquires BarioSurg 17
EnteroMedics Inc, Key Competitors 18
EnteroMedics Inc, Key Employees 19
EnteroMedics Inc, Subsidiaries 20
List of Figures
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
EnteroMedics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
EnteroMedics Inc, Medical Devices Deals, 2011 to YTD 2017 10
